What is the most likely diagnosis for a 20-year-old woman with a 1-year history of significant weight gain, excessive sleepiness, poor concentration, interpersonal sensitivity, and feelings of worthlessness, with a prior history of being gregarious and enjoying life?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Major Depressive Disorder

This patient meets diagnostic criteria for Major Depressive Disorder (MDD), not a personality disorder or persistent depressive disorder, based on the acute onset, 1-year duration, and presence of at least 5 cardinal symptoms with significant functional impairment. 1, 2

Diagnostic Reasoning

Why Major Depressive Disorder is Correct

The patient fulfills the American Psychiatric Association's criteria for MDD, which requires at least 5 symptoms present during the same 2-week period (and persisting beyond), with at least one being either depressed mood or loss of interest/pleasure 1, 3, 2:

Present symptoms in this case:

  • Depressed mood ("worthless and couldn't care less") 1
  • Loss of interest/pleasure (no longer gregarious, doesn't enjoy life) 1, 3
  • Significant weight gain (40 pounds) 1, 3
  • Hypersomnia ("feels like sleeping all day") 1, 3
  • Fatigue/loss of energy (implied by hypersomnia and functional decline) 1, 3
  • Feelings of worthlessness ("I'm worthless") 1, 3
  • Diminished concentration ("concentration is poor") 1, 3
  • Interpersonal sensitivity causing distress to others 2

Critical distinguishing features:

  • Duration of 1 year with clear onset (previously gregarious and enjoyed life) indicates an episodic disorder, not a chronic/persistent condition 4, 2
  • Normal physical exam and negative drug screen rule out medical causes and substance-induced mood disorder 1, 2
  • Significant functional impairment ("causing distress to everyone around her") meets the requirement for clinically significant distress 1, 3

Why Other Diagnoses Are Incorrect

Persistent Depressive Disorder (Dysthymia) is excluded because it requires depressed mood on most days for at least 2 years, not 1 year 4, 5, 6. The American College of Physicians clearly states that dysthymia has a mean episode duration of 3-4 years in young adults and requires chronic symptoms for at least 2 years 4. This patient has only 1 year of symptoms 4, 5.

Borderline Personality Disorder is excluded because:

  • Personality disorders represent lifelong patterns beginning in adolescence, not acute changes with clear onset 2
  • The patient had a premorbid period of normal functioning ("gregarious and enjoyed life") 2
  • The presentation is dominated by neurovegetative symptoms (weight gain, hypersomnia, poor concentration) rather than identity disturbance, unstable relationships, or impulsivity 3, 2

Bipolar II Disorder is excluded because there is no history of hypomanic episodes 1. The American Psychiatric Association criteria specify that symptoms must not meet criteria for a mixed episode, and there is no mention of periods of elevated mood, decreased need for sleep, increased goal-directed activity, or other hypomanic features 1.

Cyclothymia is excluded because it requires at least 2 years of numerous periods with hypomanic and depressive symptoms that do not meet full criteria for major depressive or hypomanic episodes 4. This patient has a single 1-year episode of full depressive symptoms 4.

Clinical Implications

The diagnosis of MDD in a young adult with atypical features (hypersomnia, increased appetite/weight gain, interpersonal sensitivity) suggests consideration of MDD with atypical features as a specifier, though this does not change the primary diagnosis 7, 8.

Treatment should be initiated promptly with either selective serotonin reuptake inhibitors (SSRIs) as first-line pharmacotherapy or evidence-based psychotherapy 9, 2. The FDA indicates fluoxetine is approved for treatment of major depressive disorder in both adults and adolescents 9. Treatment should continue for at least 16 to 24 weeks to prevent recurrence 2.

Suicide risk assessment is mandatory as recurrent thoughts of death or suicidal ideation are part of the diagnostic criteria and have critical safety implications 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnóstico y Criterios de Episodio Depresivo Mayor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dysthymia vs Depression: Key Differences

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Melancholic Depression: Definition and Clinical Features

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Major depressive disorder.

Nature reviews. Disease primers, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.